Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 30
Dermatol Online J ; 27(10)2021 Oct 15.
Article in English | MEDLINE | ID: covidwho-1643787


Social distancing requirements associated with the COVID-19 pandemic have allowed for the expansion of different healthcare delivery modalities. Namely, there has been an increase in the utilization of remote diagnostic services for both primary and specialist care. Dermatology care has traditionally been inaccessible to many pediatric patients; this is due in part to a limited number of practicing pediatric dermatologists, as well as a maldistribution of the pediatric dermatology workforce with the majority of providers located in large metropolitan areas. There is therefore a need for an accessible alternative for care to reach underserved patient populations. This commentary highlights evidence from recent studies on remote dermatology care (teledermatology) and how it has not only improved access to dermatologic care but also quality of care. Although teledermatology does not completely replace traditional in-person visits and is limited by poor broadband access in traditionally underserved areas, teledermatology can, in some instances, be a cost-effective and efficient alternative for pediatric patients otherwise lacking dermatologic care.

COVID-19/epidemiology , Dermatologists/supply & distribution , Dermatology/methods , Health Services Accessibility , Telemedicine , Child , Child, Preschool , Dermatology/statistics & numerical data , Health Services Accessibility/statistics & numerical data , Healthcare Disparities/statistics & numerical data , Humans , Infant , Infant, Newborn , Pediatricians/supply & distribution , Telemedicine/statistics & numerical data
Dermatol Surg ; 48(2): 187-190, 2022 02 01.
Article in English | MEDLINE | ID: covidwho-1595787


BACKGROUND: The Covid-19 Pandemic prompted the widespread implementation of telemedicine across healthcare. OBJECTIVE: To analyze telemedicine adoption by Mohs Micrographic surgeons (MMS) during the COVID-19 pandemic; to analyze the attitudes and perceived barriers to its long-term continuation by MMS practices. METHODS AND MATERIALS: An online multiple-choice survey was distributed to members of the American College of Mohs Surgeons. RESULTS: 86.1% of surveyed Mohs surgeons initiated telemedicine during the pandemic surge. The most common uses for telemedicine amongst respondents were post-surgery management (77.4%), "spot checks" (60.9%), and surgical consultations (59.1%). 73.1% report patients were receptive to telemedicine. 68.6% believe that telemedicine has a place in dermatologic surgery; 49.5% plan to incorporate telemedicine into their surgical practices long-term. Physical exam limitations, fitting telemedicine into practice workflow, and patient reception/patient training were viewed as the most significant barriers to long-term implementation. CONCLUSIONS: While valuable use cases for telemedicine were identified with most Mohs surgeon respondents feeling that telemedicine has a place in their practices, there is uncertainty in how to implement telemedicine into the dermatologic surgery practice workflow.

COVID-19 , Dermatology/statistics & numerical data , Mohs Surgery , Telemedicine/statistics & numerical data , Attitude of Health Personnel , COVID-19/prevention & control , Dermatology/organization & administration , Humans , Patient Education as Topic , Patient Satisfaction , Physical Examination , Pilot Projects , Postoperative Care , Referral and Consultation , SARS-CoV-2 , Surveys and Questionnaires , Workflow
Dermatol Online J ; 26(12)2020 Dec 15.
Article in English | MEDLINE | ID: covidwho-1017550


Owing to the COVID-19 outbreak, the use of telemedicine applications has increased throughout the United States. Using an algorithm to analyze mobile application rankings, we were able to examine how applications with telemedicine services have increased in prevalence and rank pre- and post- COVID-19. Telemedicine apps saw an increase of 210.92 ranked positions on average. Within US telehealth, skin conditions have become the fifth most common diagnosis. Widespread use of teledermatology has been well-accepted. Dermatologists and patients report high satisfaction using teledermatology during COVID-19 and intend to continue using these services in the future. COVID-19 has assisted in reducing physician concerns previously preventing some dermatologists from utilizing teledermatology in their services. Additionally, the geographical and socioeconomic barriers preventing some patients from receiving dermatologic care have been minimized through the use of teledermatology. Addressing these obstacles for dermatologic care improves healthcare equity.

COVID-19/epidemiology , Dermatology/statistics & numerical data , Epidemics , SARS-CoV-2 , Telemedicine/statistics & numerical data , Attitude of Health Personnel , COVID-19/psychology , Dermatology/trends , Humans , Mobile Applications , Patient Preference , Patient Satisfaction , Telemedicine/trends , United States